Ovarian Cancer
CA-125 level used to predict non-optimal primary cytoreduction of ovarian cancer
Published in Women's Health Weekly, March 16th, 2006
According to a recent article, researchers in Israel conducted a study "to provide a large database of pre-operative CA-125 levels which may predict inappropriate cytoreductive surgery in patients with advanced epithelial, ovarian cancer. A multicenter review of the records of 424 patients with FIGO stage III and IV epithelial ovarian cancer of patients who underwent primary cytoreductive surgery was performed. The validity of pre-operative CA-125 level measurement as a single predictor of the possibility to achieve only suboptimal cytoreduction was evaluated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Asthma
Asthma risk is increased by hormone replacement therapy and overweight - Breast Cancer
Acute pain following breast cancer surgery was focus of study - Cardiology
Percutaneous coronary intervention may be linked to vascular complications in women - Osteoporosis
Anorexia nervosa-related bone loss may benefit from bone formation enhancers - Osteoporosis
Historical height loss predicts vertebral fracture with high degree of accuracy - Adverse Drug Reaction
Osteonecrosis of the jaw related to pamidronate therapy - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
